Patents by Inventor Kevin Brogle

Kevin Brogle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016813
    Abstract: The present disclosure relates to methods of treating at least one symptom of a coronavirus infection, or preventing an acute inflammatory response, e.g., a cytokine storm in a coronavirus patient, in particular a SARS-CoV-19 patient, by administering an angiontensin converting enzyme-2 (ACE2) modulator.
    Type: Application
    Filed: September 9, 2021
    Publication date: January 18, 2024
    Inventors: Kevin Brown, Kevin Brogle
  • Publication number: 20230310469
    Abstract: The present disclosure relates to methods of treating at least one symptom of a coronavirus infection, or preventing an acute inflammatory response, e.g., a cytokine storm in a coronavirus patient, in particular a SARS-CoV-19 patient, by administering a Toll-Like-Receptor (TLR) agonist, in particular a TLR-7 or TLR-8 agonist.
    Type: Application
    Filed: August 30, 2021
    Publication date: October 5, 2023
    Inventors: Kevin Brown, Kevin Brogle
  • Publication number: 20230113114
    Abstract: The present disclosure relates to a method of reducing or arresting viral load in a subject infected with a coronavirus, the method comprising the step of administering to the subject a therapeutically effective amount of a viral protease inhibitor. In some embodiments, the subject is a human. In one embodiment, the coronavirus is SARS-CoV-19 and the viral protease inhibitor is E)-N-(4-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide; (R)-3-((2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-phenylbutanoyl)-5,5-dimethyl-N-(2-methylbenzyl)thiazolidine-4-carboxamide; R)—N-allyl-3-((2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-phenylbutanoyl)-5,5-dimethylthiazolidine-4-carboxamide; (4-((N-(5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-6-yl)methylsulfonamido)methyl)-2-fluorophenyl)boronic acid or salts thereof.
    Type: Application
    Filed: October 28, 2021
    Publication date: April 13, 2023
    Inventors: Kevin Brown, Kevin Brogle
  • Patent number: 11609917
    Abstract: A system and method for extrapolating a set of specific representational identifiers that are represented or covered by a generic representational identifier found in a target document. Queries are constructed and performed on a corpus of source documents in which members of the extrapolated set of specific representational identifiers are compared to a database of representational data. By matching representational data in this way, any overlap between the generic representational data and specific instances of the generic representational identifier within the source documents is determined. In a more specific implementation, the system and method reduces the scope of the generic representational identifier such that the reduced scope generic representational identifier encompasses only novel specific representational identifiers.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: March 21, 2023
    Assignee: ACCENCIO LLC
    Inventors: Paul Blake, Kevin Brogle, Kevin Brown, Don Kyle
  • Patent number: 11494387
    Abstract: A system and method for extrapolating a set of specific representational identifiers that are represented or covered by a generic representational identifier found in a target document. Queries are constructed and performed on a corpus of source documents in which members of the extrapolated set of specific representational identifiers are compared to a database of representational data. By matching representational data in this way, any overlap between the generic representational data and specific instances of the generic representational identifier within the source documents is determined. In a more specific implementation, the system and method reduces the scope of the generic representational identifier such that the reduced scope generic representational identifier encompasses only novel specific representational identifiers.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: November 8, 2022
    Assignee: PURDUE PHARMA L.P.
    Inventors: Paul Blake, Kevin Brogle, Kevin Brown, Don Kyle
  • Publication number: 20220223232
    Abstract: The present invention is directed to generating an n-dimensional map using the results of a query for compounds enumerated within a collection of documents describing a particular biological target of interest and a curated set of sequences, such as but not limited to, protein or nucleotide sequences not enumerated in the collection of documents. Both sets of sequences (document coded and curated coded) are converted into coded forms and placed in the n-dimensional map. One or more processors are configured to evaluate the distance between the curated coded forms and the closest cluster of document coded forms. Based on the distance between a coded form and the document coded forms, the curated coded forms can be ranked regarding the likelihood of interacting with the particular biological target.
    Type: Application
    Filed: January 10, 2022
    Publication date: July 14, 2022
    Inventors: Kevin Brown, Kevin Brogle
  • Publication number: 20220027374
    Abstract: The present invention is directed to generating an n-dimensional map using the results of a query for compounds enumerated within a collection of documents describing a particular biological target of interest and a curated set of compounds not enumerated in the collection of documents. Both sets of compounds (document coded and curated coded) are converted into coded forms and placed in the n-dimensional map. One or more processors are configured to evaluate the distance between the curated coded forms and the closest cluster of document coded forms. Based on the distance between a coded form and the document coded forms, the curated coded forms can be ranked regarding the likelihood of interacting with the particular biological target.
    Type: Application
    Filed: July 22, 2021
    Publication date: January 27, 2022
    Inventors: Kevin Brown, Kevin Brogle
  • Patent number: 10372713
    Abstract: A system and method for extrapolating a set of specific representational identifiers that are represented or covered by a generic representational identifier found in a target document. Queries are constructed and performed on a corpus of source documents in which members of the extrapolated set of specific representational identifiers are compared to a database of representational data. By matching representational data in this way, any overlap between the generic representational data and specific instances of the generic representational identifier within the source documents is determined. In a more specific implementation, the system and method reduces the scope of the generic representational identifier such that the reduced scope generic representational identifier encompasses only novel specific representational identifiers.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: August 6, 2019
    Assignee: PURDUE PHARMA L.P.
    Inventors: Paul Blake, Kevin Brogle, Kevin Brown, Don Kyle
  • Patent number: 10013467
    Abstract: The present invention concerns a system and method for analyzing the relationship between representational data found in source documents through creation and manipulation of a virtual manifold, such as a node array. Furthermore, the present invention concerns predicting new representational data based on the representational data found within the source documents. The system and method further utilizes a processor configured to carry out a series of steps in order to create, maintain and manage associations between source documents, the representational identifiers found within the source documents, and any converted coded forms of the representational identifiers.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: July 3, 2018
    Assignee: PURDUE PHARMA L.P.
    Inventor: Kevin Brogle